Relationship between plasma apelin level and coronary collateral circulation

Atherosclerosis

Volumn 235, Issue 2, 2015, Pages 289-294

  Akboga, Mehmet Kadri ^a   Akyel, Ahmet ^b   Sahinarslan, Asife ^c   Demirtas, Canan Yilmaz ^c   Yayla, Cagri ^c   Boyaci, Bulent ^c   Yalcin, Ridvan ^c  

^a MINISTRY OF HEALTH   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Angiogenesis; Apelin; Collateral circulation; Coronary artery disease

Indexed keywords

APELIN; NITRIC OXIDE; APLN PROTEIN, HUMAN; BIOLOGICAL MARKER; SIGNAL PEPTIDE;

ADULT; ANGIOCARDIOGRAPHY; APELIN BLOOD LEVEL; ARTICLE; CLASSIFICATION; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY OCCLUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENTROP COHEN CLASSIFICATION; STABLE ANGINA PECTORIS; BLOOD; COLLATERAL CIRCULATION; CORONARY ARTERY BLOOD FLOW; DRUG EFFECTS; PHYSIOLOGY;

BIOLOGICAL MARKERS; COLLATERAL CIRCULATION; CORONARY CIRCULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;

EID: 84921451621     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.04.029     Document Type: Article

References (38)

1. Billinger M., Kloos P., Eberli F.R., Windecker S., Meier B., Seiler C. Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow up study in 403 patients with coronary artery disease. J Am Coll Cardiol 2002, 40:1545-1550.
2. Habib G.B., Heibig J., Forman S.A., Brown B.G., Roberts R., Terrin M.L., et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991, 83:739-746.
3. Hansen J.F. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989, 117:290-295.
4. Matsunaga T., Warltier D.C., Weihrauch D., Moniz M., Tessmer J., Chilian W.M. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000, 102:3098-3103.
5. Sellke F.W., Wang S.Y., Stamler A., Lopez J.J., Li J., Simons M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol 1996, 271:713-720.
6. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251:471-476.
7. Sorli S.C., Le Gonidec S., Knibiehler B., Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007, 26:7692-7699.
8. Kidoya H., Ueno M., Yamada Y., Mochizuki N., Nakata M., Yano T., et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 2008, 27:522-534.
9. Masri B., Morin N., Cornu M., Knibiehler B., Audigier Y. Apelin activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 2004, 18:1909-1911.
10. Fraker T.D., Fihn S.D., Gibbons R.J., Abrams J., Chatterjee K., Daley J., et al. Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007, 50:2264-2274.
11. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5:587-592.
12. Meier P., Hemingway H., Lansky A.J., Knapp G., Pitt B., Seiler C. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J 2012, 33:614-621.
13. Regieli J.J., Jukema J.W., Nathoe H.M., Zwinderman A.H., Ng S., Grobbee D.E., et al. Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol 2009, 132:257-262.
14. Grisar J., Aletaha D., Steiner C.W., Kapral T., Steiner S., Seidinger D., et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005, 111:204-211.
15. Kadi H., Ceyhan K., Karayakali M., Koç F., Celik A., Onalan O. The relationship between coronary collateral circulation and blood high-sensitivity C-reactive protein levels. Turk Kardiyol Dern Ars 2011, 39:23-28.
16. Solorio S., Murillo-Ortíz B., Hernández-González M., Guillén-Contreras J., Arenas-Aranda D., Solorzano-Zepeda F.J., et al. Association between telomere length and C-reactive protein and the development of coronary collateral circulation in patients with coronary artery disease. Angiology 2011, 62:467-472.
17. Kasapkara H.A., Topsakal R., Yarlioglues M., Yarlioglues G., Dogdu O., Ardic I., et al. Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis 2012, 23:421-425.
18. Uysal O.K., Sahin D.Y., Duran M., Turkoglu C., Yildirim A., Elbasan Z., et al. Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology 2013 Aug 21, [Epub ahead of print].
19. Werner G.S., Jandt E., Krack A., Schwarz G., Mutschke O., Kuethe F., et al. Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 2004, 110:1940-1945.
20. Goukassian D.A., Qin G., Dolan C., Murayama T., Silver M., Curry C., et al. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 2007, 115:752-762.
21. Sahinarslan A., Kocaman S.A., Topal S., Ercin U., Bukan N., Yalcin R., et al. Relation between serum monocyte chemoattractant protein-1 and coronary collateral development. Coron Artery Dis 2010, 21:455-459.
22. Boucher J., Masri B., Daviaud D., Gesta S., Guigné C., Mazzucotelli A., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146:1764-1771.
23. Szokodi I., Tavi P., Foldes G. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002, 91:434-440.
24. Roberts E.M., Newson M.J., Pope G.R., Landgraf R., Lolait S.J., O'Carroll A.M. Abnormal fluid homeostasis in apelin receptor knockout mice. J Endocrinol 2009, 202:453-462.
25. Habata Y., Fujii R., Hosoya M., Fukusumi S., Kawamata Y., Hinuma S., et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999, 1452:25-35.
26. Kasai A., Shintani N., Oda M., Kakuda M., Hashimoto H., Matsuda T., et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004, 325:395-400.
27. Zhang B.H., Guo C.X., Wang H.X., Lu L.Q., Wang Y.J., Zhang L.K., et al. Cardioprotective effects of adipokine apelin on myocardial infarction. Heart Vessels 2013 Oct 19, [Epub ahead of print]. 10.1007/s00380-013-0425-z.
28. Kalin R.E., Kretz M.P., Meyer A.M., Kispert A., Heppner F.L., Brandli A.W. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol 2007, 305:599-614.
29. Kidoya H., Naito H., Takakura N. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 2010, 115:3166-3174.
30. Tiani C., Garcia-Pras E., Mejias M., de Gottardi A., Berzigotti A., Bosch J., et al. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. J Hepatol 2009, 50:296-305.
31. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001, 99:87-92.
32. Kleinz M.J., Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005, 107:198-211.
33. Pohl T., Seiler C., Billinger M., Herren E., Wustmann K., Mehta H., et al. Frequency distribution of collateral flow and factors influencing collateral channel development. J Am Coll Cardiol 2001, 38:1872-1878.
34. van der Hoeven N.W., Teunissen P.F., Werner G.S., Delewi R., Schirmer S.H., Traupe T., et al. Clinical parameters associated with collateral development in patients with chronic total coronary occlusion. Heart 2013, 99:1100-1105.
35. Sun Zhen, Shen Ying, Lu Lin, Zhang R.Y., Pu L.J., Zhang Q., et al. Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion. J Zhejiang Univ Sci B 2013, 14:705-712.
36. Koerselman J., de Jaegere P.P., Verhaar M.C., Grobbee D.E., van der Graaf Y. SMART Study Group. Coronary collateral circulation: the effects of smoking and alcohol. Atherosclerosis 2007, 191:191-198.
37. Cohen M., Sherman W., Rentrop K.P., Gorlin R. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol 1989, 13:297-303.
38. Kilian J.G., Keech A., Adams M.R., Celermajer D.S. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 2002, 13:155-159.